SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics (NASDAQ:MBRX) announced today that it will host a conference call and live webcast on Thursday, November 1, 2007, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter of 2007 and other recent Company events. Dr. Paul Laikind, president and chief executive officer, Mr. John Beck, senior vice president of finance and chief financial officer, and Dr. Mark Erion, executive vice president of research and development and chief scientific officer, will participate in the call.
